136 related articles for article (PubMed ID: 37272424)
1. Cemtirestat, an aldose reductase inhibitor and antioxidant compound, induces ocular defense against oxidative and inflammatory stress in rat models for glycotoxicity.
Reihanifar T; Şahin M; Stefek M; Ceylan AF; Karasu Ç;
Cell Biochem Funct; 2023 Aug; 41(6):622-632. PubMed ID: 37272424
[TBL] [Abstract][Full Text] [Related]
2. A dual-acting aldose reductase inhibitor impedes oxidative and carbonyl stress in tissues of fructose- and streptozotocin-induced rats: comparison with antioxidant stobadine.
Kaya A; Ceylan AF; Kavutcu M; Santamaria A; Šoltésová Prnová M; Stefek M; Karasu Ç
Drug Chem Toxicol; 2023 Oct; ():1-11. PubMed ID: 37795621
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine.
Elmazoglu Z; Prnova MS; Stefek M; Ceylan AF; Aschner M; Rangel-López E; Santamaria A; Karasu C
Neurotox Res; 2021 Jun; 39(3):588-597. PubMed ID: 33713301
[TBL] [Abstract][Full Text] [Related]
4. Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
Hamada Y; Nakamura J; Naruse K; Komori T; Kato K; Kasuya Y; Nagai R; Horiuchi S; Hotta N
Diabetes Care; 2000 Oct; 23(10):1539-44. PubMed ID: 11023149
[TBL] [Abstract][Full Text] [Related]
5. Combatting Nitrosative Stress and Inflammation with Novel Substituted Triazinoindole Inhibitors of Aldose Reductase in PC12 Cells Exposed to 6-Hydroxydopamine Plus High Glucose.
Elmazoglu Z; Prnova MS; Santamaria A; Stefek M; Karasu C
Neurotox Res; 2021 Apr; 39(2):210-226. PubMed ID: 33146867
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat-another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats.
Prnova MS; Kovacikova L; Svik K; Bezek S; Elmazoğlu Z; Karasu C; Stefek M
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):651-661. PubMed ID: 31802170
[TBL] [Abstract][Full Text] [Related]
7. 3-Mercapto-5H-1,2,4-Triazino[5,6-b]Indole-5-Acetic Acid (Cemtirestat) Alleviates Symptoms of Peripheral Diabetic Neuropathy in Zucker Diabetic Fatty (ZDF) Rats: A Role of Aldose Reductase.
Soltesova Prnova M; Svik K; Bezek S; Kovacikova L; Karasu C; Stefek M
Neurochem Res; 2019 May; 44(5):1056-1064. PubMed ID: 30689163
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.
Obrosova IG; Minchenko AG; Vasupuram R; White L; Abatan OI; Kumagai AK; Frank RN; Stevens MJ
Diabetes; 2003 Mar; 52(3):864-71. PubMed ID: 12606532
[TBL] [Abstract][Full Text] [Related]
9. Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress.
Yülek F; Or M; Ozoğul C; Isik AC; Ari N; Stefek M; Bauer V; Karasu C
Arch Med Res; 2007 Jul; 38(5):503-11. PubMed ID: 17560455
[TBL] [Abstract][Full Text] [Related]
10. Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathway.
Du L; Hao M; Li C; Wu W; Wang W; Ma Z; Yang T; Zhang N; Isaac AT; Zhu X; Sun Y; Lu Q; Yin X
Mol Cell Endocrinol; 2017 Sep; 452():44-56. PubMed ID: 28501572
[TBL] [Abstract][Full Text] [Related]
11. The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation.
He J; Gao HX; Yang N; Zhu XD; Sun RB; Xie Y; Zeng CH; Zhang JW; Wang JK; Ding F; Aa JY; Wang GJ
Acta Pharmacol Sin; 2019 Jan; 40(1):86-97. PubMed ID: 29930278
[TBL] [Abstract][Full Text] [Related]
12. Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.
Mizuno K; Kato N; Makino M; Suzuki T; Shindo M
J Diabetes Complications; 1999; 13(3):141-50. PubMed ID: 10509874
[TBL] [Abstract][Full Text] [Related]
13. Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats.
Shi X; Liao S; Mi H; Guo C; Qi D; Li F; Zhang C; Yang Z
Molecules; 2012 Nov; 17(11):12868-81. PubMed ID: 23117428
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
Obrosova IG; Fathallah L
Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Basso M; Hohman TC
Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
[TBL] [Abstract][Full Text] [Related]
16. Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway.
Li QR; Wang Z; Zhou W; Fan SR; Ma R; Xue L; Yang L; Li YS; Tan HL; Shao QH; Yang HY
Neural Regen Res; 2016 Feb; 11(2):345-51. PubMed ID: 27073391
[TBL] [Abstract][Full Text] [Related]
17. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dipeptidyl peptidase-4 (DPP4), antioxidant, antiglycation and anti-inflammatory effect of Ferulic acid against streptozotocin toxicity mediate nephropathy in diabetic rats.
Al-Ghamdi MA; Moselhy SS
Environ Sci Pollut Res Int; 2023 Mar; 30(12):33942-33948. PubMed ID: 36496522
[TBL] [Abstract][Full Text] [Related]
19. Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.
Ashizawa N; Yoshida M; Sugiyama Y; Akaike N; Ohbayashi S; Aotsuka T; Abe N; Fukushima K; Matsuura A
Jpn J Pharmacol; 1997 Feb; 73(2):133-44. PubMed ID: 9074947
[TBL] [Abstract][Full Text] [Related]
20. Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E.
Ulusu NN; Sahilli M; Avci A; Canbolat O; Ozansoy G; Ari N; Bali M; Stefek M; Stolc S; Gajdosik A; Karasu C
Neurochem Res; 2003 Jun; 28(6):815-23. PubMed ID: 12718433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
